SCI Abstract

search
+
Pronounced ethnic and sex disparities in gastric cancer burden and healthcare utilization in Inner Mongolia: a 9-year population-based cohort study 
Pronounced ethnic and sex disparities in gastric cancer burden and healthcare utilization in Inner Mongolia: a 9-year population-based cohort study 
Gastric cancer (GC) remains a major public health concern in China. This study assessed the epidemiology and healthcare ut...
Diagnostic discordance and treatment-associated change of PD-L1 and CLDN18.2 in gastric cancer: a real-world analysis of paired biopsy–resection samples
Diagnostic discordance and treatment-associated change of PD-L1 and CLDN18.2 in gastric cancer: a real-world analysis of paired biopsy–resection samples
Programmed death-ligand 1 (PD-L1) and claudin 18.2 (CLDN18.2) are key biomarkers informing systemic therapy in advanced ga...
Therapeutic value of para-aortic lymph node dissection in gastric cancer with extensive lymph node metastasis: integrated analysis of three phase II trials (JCOG2212A)
Therapeutic value of para-aortic lymph node dissection in gastric cancer with extensive lymph node metastasis: integrated analysis of three phase II trials (JCOG2212A)
Japan Clinical Oncology Group (JCOG) defined gastric cancer (GC) with bulky lymph node (Bulky N) and/or para-aortic lymph ...
Simple clinical parameters to identify sarcopenia 1 year after gastrectomy for gastric cancer
Simple clinical parameters to identify sarcopenia 1 year after gastrectomy for gastric cancer
New-onset sarcopenia may develop after gastrectomy even in patients with normal muscle mass, but its detection in routine ...
Total versus subtotal gastrectomy following neoadjuvant flot chemotherapy for distal diffuse gastric adenocarcinoma: an international cohort study
Total versus subtotal gastrectomy following neoadjuvant flot chemotherapy for distal diffuse gastric adenocarcinoma: an international cohort study
To compare perioperative, oncological, and survival outcomes of total gastrectomy (TG) versus subtotal gastrectomy (SG) in...
Exercise–nutrition prehabilitation attenuates lean body mass loss before gastrectomy: a randomized controlled trial
Exercise–nutrition prehabilitation attenuates lean body mass loss before gastrectomy: a randomized controlled trial
Older patients undergoing gastrectomy frequently exhibit sarcopenia and reduced physiologic reserve, increasing vulnerabil...
A phase II trial of ramucirumab and docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903)
A phase II trial of ramucirumab and docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903)
Ramucirumab has shown efficacy in combination with paclitaxel in the second-line treatment of advanced gastric cancer (AGC...
The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials
The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials
Tumour infiltrating lymphocytes (TILs) are a key component of the tumour microenvironment. To establish a clinically relev...
Zolbetuximab plus chemotherapy in Japanese patients with claudin 18.2–positive gastric or gastroesophageal junction adenocarcinoma: a combined subgroup analysis of the phase 3 SPOTLIGHT and GLOW trials
Zolbetuximab plus chemotherapy in Japanese patients with claudin 18.2–positive gastric or gastroesophageal junction adenocarcinoma: a combined subgroup analysis of the phase 3 SPOTLIGHT and GLOW trials
Zolbetuximab is a monoclonal antibody targeting claudin 18 isoform 2 (CLDN18.2) approved for first-line treatment of CLDN1...
Comparison of long-term outcomes of robotic gastrectomy and laparoscopic gastrectomy using the modified age-adjusted Charlson Comorbidity Index
Comparison of long-term outcomes of robotic gastrectomy and laparoscopic gastrectomy using the modified age-adjusted Charlson Comorbidity Index
The modified age-adjusted Charlson Comorbidity Index (mACCI) is associated with postoperative complications and long-term ...
Argon plasma coagulation, endoscopic mucosal resection, and endoscopic submucosal dissection for gastric low-grade dysplasia: a multicenter inverse probability–weighted cohort study
Argon plasma coagulation, endoscopic mucosal resection, and endoscopic submucosal dissection for gastric low-grade dysplasia: a multicenter inverse probability–weighted cohort study
Argon plasma coagulation (APC) has been proposed for the treatment of gastric low-grade dysplasia (LGD), but comparative d...
Plasma proteomic signatures improve risk stratification and personalized screening for gastric cancer
Plasma proteomic signatures improve risk stratification and personalized screening for gastric cancer
Accurate identification of individuals at high risk of gastric cancer (GC) remains a major challenge for effective screeni...
Artificial intelligence–based anatomical recognition improves surgeon decision-making during robotic gastrectomy
Artificial intelligence–based anatomical recognition improves surgeon decision-making during robotic gastrectomy
Artificial intelligence (AI)–based anatomical recognition has emerged to support intraoperative cognition; however, ...
Prognostic implications of tissue-based homologous recombination deficiency in metastatic gastric cancer treated with immune checkpoint inhibitor plus chemotherapy
Prognostic implications of tissue-based homologous recombination deficiency in metastatic gastric cancer treated with immune checkpoint inhibitor plus chemotherapy
Homologous recombination deficiency (HRD), a genomic instability phenotype resulting from impaired DNA repair, has been as...
Circulating tumor DNA-guided response evaluation in patients with previously treated gastroesophageal adenocarcinoma
Circulating tumor DNA-guided response evaluation in patients with previously treated gastroesophageal adenocarcinoma
Systemic treatment offers only modest survival benefits in previously treated metastatic gastroesophageal adenocarcinoma (...
Feasibility study of cap-assisted endoscopic mucosal resection for gastric adenocarcinoma of fundic gland type
Feasibility study of cap-assisted endoscopic mucosal resection for gastric adenocarcinoma of fundic gland type
Gastric adenocarcinoma of fundic gland type (GA-FG) is a rare subtype that typically arises in the upper stomach, making e...
Clinical advantages of robotic gastrectomy for gastric cancer over conventional laparoscopic approach: a retrospective cohort study using a nationwide registry database in Japan
Clinical advantages of robotic gastrectomy for gastric cancer over conventional laparoscopic approach: a retrospective cohort study using a nationwide registry database in Japan
To evaluate contemporary short-term outcomes of robotic gastrectomy (RG) approximately 5 years after its widespre...
Hospital-based gastric cancer outcomes in the United States (2003–2022): racial and regional disparities
Hospital-based gastric cancer outcomes in the United States (2003–2022): racial and regional disparities
Racial disparities in gastric cancer (GC) outcomes have gained increasing attention in the United States, particularly giv...
Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cells
Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cells
The tyrosine kinase inhibitor (TKI) imatinib targets KIT and PDGFRA, offering significant therapeutic benefits in advanced...
Time-sequential prediction of postoperative complications after gastric cancer surgery using machine learning: a multicenter cohort study
Time-sequential prediction of postoperative complications after gastric cancer surgery using machine learning: a multicenter cohort study
Although many studies have developed logistic regression models for predicting complications using preoperative and intrao...
Eligibility criteria in phase 3 randomized controlled trials in gastric cancer
Eligibility criteria in phase 3 randomized controlled trials in gastric cancer
The purpose of this study was to examine the eligibility criteria in phase 3 randomized controlled trials (RCTs) in gastri...
Development and validation of a prognostic model incorporating patient reported outcomes for advanced gastric and esophageal carcinoma (AGOC) using individual patient data from two AGITG randomized clinical trials
Development and validation of a prognostic model incorporating patient reported outcomes for advanced gastric and esophageal carcinoma (AGOC) using individual patient data from two AGITG randomized clinical trials
We developed and validated a prognostic model incorporating readily accessible clinicopathological data and specific patie...
Angiotensin receptor blocker and angiotensin-converting enzyme inhibitor use and survival in gastric cancer patients: a Finnish nationwide cohort study
Angiotensin receptor blocker and angiotensin-converting enzyme inhibitor use and survival in gastric cancer patients: a Finnish nationwide cohort study
The renin–angiotensin system (RAS) has been increasingly recognized to be associated with carcinogenesis and cancer ...
Minimally invasive versus open completion total gastrectomy for remnant gastric cancer: a nationwide propensity score-matched analysis
Minimally invasive versus open completion total gastrectomy for remnant gastric cancer: a nationwide propensity score-matched analysis
Minimally invasive surgery (MIS) is increasingly used for gastric cancer; however, its application to remnant gastric canc...
Clinical-radiomic prognostic model integrating staging before and after neoadjuvant chemotherapy in gastric cancer: a multicenter retrospective study
Clinical-radiomic prognostic model integrating staging before and after neoadjuvant chemotherapy in gastric cancer: a multicenter retrospective study
Tumor regression grade (TRG) and ypTNM are primarily employed to evaluate the efficacy of Neoadjuvant chemotherapy (NAC) i...
Classification based on tumor phenotypes enables the novel molecular characterization of esophagogastric junction cancer
Classification based on tumor phenotypes enables the novel molecular characterization of esophagogastric junction cancer
The incidence of esophagogastric junction (EGJ) cancer is increasing worldwide. Siewert type II EGJ cancer encompasses int...
Textbook outcome in gastrectomy: useful metric or moving target? A scoping review
Textbook outcome in gastrectomy: useful metric or moving target? A scoping review
Composite metrics including Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) are increasingly utilised to asse...
Type 2 diabetes in patients undergoing gastric cancer surgery: areas requiring disease-specific glycemic management
Type 2 diabetes in patients undergoing gastric cancer surgery: areas requiring disease-specific glycemic management
This review provides a comprehensive analysis of phase-specific management strategies for type 2 diabetes (T2D) in patient...
Gallbladder edema as a clue to zolbetuximab-associated protein-losing enteropathy in gastric cancer: a case report
Gallbladder edema as a clue to zolbetuximab-associated protein-losing enteropathy in gastric cancer: a case report
We report a rare case of protein-losing enteropathy (PLE) during zolbetuximab treatment in a 73-year-old woman with Stage ...
Development of adenovirus-based oncolytic virus to induce EBV lytic reactivation
Development of adenovirus-based oncolytic virus to induce EBV lytic reactivation
Oncolytic viruses (OVs) selectively replicate in and lyse tumor cells. Epstein–Barr virus-associated gastric carcino...
Load More
format_indent_increase